Charles G. Phillips III, Director at NovoCure Ltd (NVCR), sold 43,600 shares at $90.63 ($4.0M) on 2019-08-30, disclosed to the SEC on 2019-09-03.
Open-market sale of $4.0M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.63 | 8,692 | $788K | 19.8% |
| 2 | $90.63 | 8,692 | $788K | 19.8% |
| 3 | $91.46 | 12,908 | $1.2M | 29.7% |
| 4 | $91.46 | 12,908 | $1.2M | 29.7% |
| 5 | $92.10 | 400 | $37K | 0.9% |
| Total | $91.13 avg | 43,600 |
| $4.0M |
| 100% |
| Filing → |
| NVCR | SELL | 2018-05-30 | $1.5M | — | Filing → |